Primary Objective(s): * To describe the demographic characteristics of people living with FOP and a matched cohort of non-FOP people living in the United States (U.S.) * To describe the prevalence of clinical characteristics of interest and the use of key medications in people living with FOP and a matched cohort of non-FOP people living in the U.S. * To compare the prevalence of key clinical characteristics and medication use in people living with FOP to a matched cohort of non-FOP people living in the U.S. * To estimate the crude mortality rate among people living with FOP
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Demographic characteristics
Timeframe: Up to 5 years
Prevalence of cardiovascular disease
Timeframe: Up to 5 years
Prevalence of metabolic disease
Timeframe: Up to 5 years
Prevalence of hematology disease
Timeframe: Up to 5 years
Prevalence of infection
Timeframe: Up to 5 years
Prevalence of respiratory disease
Timeframe: Up to 5 years
Prevalence of reproductive disease
Timeframe: Up to 5 years
Prevalence of neurologic disorders
Timeframe: Up to 5 years
Prevalence of skeletal disorders
Timeframe: Up to 5 years
Prevalence of gastrointestinal disease
Timeframe: Up to 5 years
Prevalence of hearing loss
Timeframe: Up to 5 years
Prevalence of dermatologic disorders
Timeframe: Up to 5 years
Prevalence of neoplasms
Timeframe: Up to 5 years
Average number of dispensations per FOP patient per year
Timeframe: Up to 5 years
Cumulative number of dispensations per FOP patient
Timeframe: Up to 5 years
Incidence of all-cause death
Timeframe: Up to 5 years